Advisory Team

The Advisory Team at BioXyTran provides strategic guidance and expertise in the development of innovative biopharmaceutical treatments for stroke and ischemia. Comprising seasoned advisors and a Medical Advisory Board, the team collaborates on clinical strategies, regulatory pathways, and research priorities, ensuring alignment with the latest scientific advancements and patient needs. Their collective insights aim to enhance the company's product development efforts and optimize clinical outcomes.